Elicio Therapeutics, Inc. - Common Stock —— 资产负债表 (NASDAQ:ELTX) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

总资产 96.51 M52.79 M27.15 M28.18 M25.86 M 负债总额 15.01 M9.02 M15.77 M39.49 M24.23 M 权益总额 81.51 M43.77 M11.37 M-11.31 M1.64 M 负债及股东权益总额 96.51 M52.79 M27.15 M28.18 M25.86 M 总债务 0——20.03 M9.41 M 净债务 0——2.42 M-9.16 M

新闻

Elicio Therapeutics: Hoping To Capitalize On Massive KRAS Hype, But Time Is Running Out

Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year?

Elicio Therapeutics启动1亿美元市场发售股票计划

H.C. Wainwright上调Elicio Therapeutics目标价至17美元

H.C. Wainwright raises Elicio Therapeutics price target to $17

Rodman & Renshaw首次覆盖Elicio Therapeutics股票,给予买入评级

Rodman & Renshaw initiates Elicio Therapeutics stock with buy rating

Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year?

Elicio Therapeutics (ELTX) Upgraded to Buy: Here's Why

Elicio reports antigen spreading in 87% of evaluated cancer patients

Elicio Therapeutics appoints Marc Wolfgang as chief technology officer

Elicio reports strong immune responses in phase 2 KRAS cancer vaccine trial